Overall treatment principles
Share with patients a written individualized treatment plan addressing each layer. The vulvar surface must be protected and strengthened, abnormal peripheral and central nerve activity suppressed, and the PF normalized with PT. Musculoskeletal abnormalities and pelvic organ pain require focused therapies, and underlying systemic conditions must be appreciated and treated. Depression, anxiety, and hopelessness are improved by supportive and cognitive behavioral therapy. Develop a relationship with a therapist who is knowledgeable about chronic pain and mind-body practices, which calm the ANS and physical consequences of pain and stress.
Anticipate pain flares and have a plan in place before they occur. Re-evaluate persistent or recurrent pain often, layer by layer. Address the side effects of medications preemptively and quickly. Avoid opioid pain relievers, which do not relieve chronic pain, but may cause bowel and bladder symptoms, endocrinopathies, sexual dysfunction, and mood and cognitive disturbances that may lead to overdose.28
Patients trust ob/gyns with the care of chronic sexual pain. Our committed partnership with patients will improve their quality of life and provide an essential component of healing: hope for the real possibility of cure.
1. Harlow BL, Kunitz CG, Nguyen RHN, et al. Prevalence of symptoms consistent with a diagnosis of vulvodynia: population-based estimates from 2 geographic regions. Am J Obstet Gynecol. 2014;210:40.
2. Mathias SD1, Kuppermann M, Liberman RF, et al. Chronic pelvic pain: prevalence, health-related quality of life, and economic correlates. Obstet Gynecol. 1996;87(3):321–327.
3. Reed BD, Harlow SD, Sen A, et al. Prevalence and demographic characteristics of vulvodynia in a population-based sample. Am J Obstet Gynecol. 2012;206:170.1–9.
4. Gardella B, Porru D, Nappi RE, et al. Interstitial cystitis is associated with vulvodynia and sexual dysfunction—a case-control study. J Sex Med. 2011;8(6):1726–1734.
5. Arnold LD, Bachmann GA, Rosen R, et al. Vulvodynia: characteristics and associations with comorbidities and quality of life. Obstet Gynecol. 2006;107:617–624.
6. Nickel JC, Tripp D, Teal V, et al. Sexual function is a determinant of poor quality of life for women with treatment refractory interstitial cystitis. J Urol. 2007;177(5):1832–1836.
7. Gerrits MM, van Oppen P, van Marijk HW,et al. Pain and the onset of depressive and anxiety disorders. Pain. 2014;155:53–59.
8. Nguyen RH, Turner RM, Rydell SA, et al. Perceived stereotyping and seeking care for chronic vulvar pain. Pain Med. 2013;10:1461–1467.
9. Price J, Farmer G, Harris J, et al. (2006), Attitudes of women with chronic pelvic pain to the gynaecological consultation: a qualitative study. BJOG. 2006;113(4):446–452.
10. Education Committee of the Council on Resident Education in Obstetrics and Gynecology. Educational Objectives: Core Curriculum in Obstetrics and Gynecology, 10th Edition, 2013. 63–64.
11. Wingenfeld K, Hellhammer DH, Schmidt I, et al. HPA axis reactivity in chronic pelvic pain: association with depression. J Psychosom Obstet Gynaecol. 2009;30(4):282–286.
12. Gouin JP, Kiecolt-Glaser J. The impact of psychological stress on wound healing: methods and mechanisms. Immunol Allergy Clin North Am. 2011;31(1):81–93.
13. Piper CK, Legocki LJ, Moravek MB, et al. Experience of symptoms, sexual function, and attitudes toward counseling of women newly diagnosed with vulvodynia. J Low Gen Tract Dis. 2012;16(4):447–453.
14. Tang YY, Ma Y, Fan Y, et al. Central and autonomic nervous system interaction is altered by short-term meditation. Proc Natl Acad Sci USA. 2009;106(22):8865–8870.
15. Wren AA, Wright MA, Carson JW, et al. Yoga for persistent pain: new findings and directions for an ancient practice. Pain. 2011;152:477–80.
16. Hummel-Berry K, Wallace K, Herman H. The reliability and validity of the Vulvar Questionnaire (VQ). J Women’s Health Physical Ther. 2006;31:28–33.
17. Leclair CM, Goetsch MF, Korcheva VB et al. Differences in primary compared with secondary vestibulodynia by immunohistochemistry. Obstet Gynecol. 2011;117:1307–1313.
18. Goldstein AT, Belkin ZR, Krapf JM, et al. Polymorphisms of the androgen receptor gene and hormonal contraceptive induced provoked vestibulodynia. J Sex Med. 2014;11:2764–2771.
19. Dellon AL, Coady D, Harris D. Pelvic pain of pudendal nerve origin: surgical outcomes and learning curve lessons. J Reconstr Microsurg. 2015;31(4):283–290.
20. Furtmüller GJ, McKenna CA, Ebmer J, Dellon AL. Pudendal nerve 3-dimensional illustration gives insight into surgical approaches. Ann Plast Surg. 2014;73:670–678.
21. Weiss PM, Rich J, Swisher E. Pelvic floor spasm: the missing link in chronic pelvic pain. Contemporary OB/GYN. October 1, 2102.
22. Hartmann D, Sarton J. Chronic pelvic floor dysfunction. Best Pract Res Clin Obstet Gynaecol. 2014; doi.org/10.1016/j.bpobgyn.
23. Prather H, Dugan S, Fitzgerald C, Hunt D. Review of anatomy, evaluation, and treatment of musculoskeletal pelvic floor pain in women. PMR. 2009;1:346-358.
24. Goetsch MF, Lim JY, Caughey AB. Locating pain in breast cancer survivors experiencing dyspareunia: a randomized controlled trial. Obstet Gynecol. 2014; 123(6):1231-6.
25. LeClaire CM, Goettsch MF, Li H, Morgan TK. Histopathologic characteristics of menopausal vestibulodynia. Obstet Gynecol. 2013;122:787-93.
26. Hampson JP, Reed BD, Clauw DJ, et al. Augmented central pain processing in vulvodynia. J Pain. 2013;14:579-89.
27. Delgado R, York A, Active Self-Care Therapies for Pain (PACT) Working Group, et al. Assessing the quality, efficacy, and effectiveness of the current evidence base of active self-care complementary and integrative medicine therapies for the management of chronic pain: a rapid evidence assessment of the literature. Pain Med. 2014;15, Suppl 1:S9-20.
28. Reuben DB, Alvanzo AAH, Ashikaga T, et al. National Institutes of Health pathways to prevention workshop: the role of opioids in the treatment of chronic pain. Ann Int Med. 2015; DOI: 10.7326/M14-2775.